<?xml version="1.0" encoding="UTF-8"?>
<p>About the scales of SF-36, SF-36PH, and SF-36MH, the mean score of these scales at the end and two weeks later from the end of the trial and its mean increase after treatment was higher than the intervention group; these differences were statistically significant (
 <xref rid="tab3" ref-type="table">Table 3</xref>). Also, the mean reduction of the score in these scales two weeks after the trial's end was lower in the intervention group. These differences were significant for the SF-36 and SF-36MH scales (
 <xref rid="tab3" ref-type="table">Table 3</xref>).
</p>
